[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Global Aesthetics LLC\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":40},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":11,"sex":15,"minAge":16,"maxAge":17,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":22,"conditions":23,"keywords":25,"overallStatus":27,"whyStopped":4,"lastUpdateSubmitDate":28,"lastUpdatePostDateStruct":29,"startDateStruct":32,"completionDateStruct":34,"leadSponsor":36,"locationsCount":39},"100545689","assessing-the-impact-of-botulinum-toxin-type-a-on-facial-wrinkles-a-comprehensive-clinical-investigation-100545689",false,"NCT06385171","Assessing the Impact of Botulinum Toxin Type A on Facial Wrinkles: A Comprehensive Clinical Investigation","Inclusion Criteria:\n\n* Individuals of both genders.\n* Must be in good physical health.\n* Age between 20 and 65 years.\n* Presence of both static (unchanging) and moderate dynamic (movement-induced) wrinkles on the forehead or glabellar region.\n* Must possess the willingness and ability to understand and provide informed consent, as well as effectively communicate with study personnel.\n\nExclusion Criteria:\n\n* Pregnant or breastfeeding female.\n* Age below 20 or above 65 years.\n* History of neuromuscular disorders, such as myasthenia gravis.\n* History of facial surgery or presence of scars in the treatment area that could potentially interfere with or confound the results of the study.\n* Recent treatment history within the past 6 months in the forehead or glabellar region, including:\n* Ablative laser procedures.\n* Radiofrequency device treatments.\n* Ultrasound device treatments.\n* Medium to deep chemical peels.\n* Temporary soft tissue augmentation.\n* Semi-permanent soft tissue augmentation within the past 2 years.\n* Permanent soft tissue augmentation.\n* Planned cosmetic procedures within the next 6 months in the same region.\n* Intended use of tretinoin or retinoic acid within the next 6 months.\n* Presence of active infection in the treated area, excluding mild acne.\n* Allergy to cow's milk protein or albumin.\n* Use of aminoglycoside medications.\n* Current use of anticoagulation therapy.\n* History of bleeding disorders.\n* Diagnosis of mental illness.\n* Inability to comprehend the study protocol or provide informed consent.","ALL","20 Years","65 Years",{"count":19,"type":20},500,"ESTIMATED","OBSERVATIONAL","A study conducting to see how well a treatment called Botulinum Toxin Type A works for reducing facial wrinkles. The study will help us understand if this treatment is safe and effective for making wrinkles on the face less noticeable.",[24],"Wrinkle",[26],"Facial Wrinkles","RECRUITING","2024-05-23",{"date":30,"type":31},"2024-05-24","ACTUAL",{"date":33,"type":31},"2024-05-22",{"date":35,"type":20},"2027-01-05",{"name":37,"class":38},"Global Aesthetics LLC","OTHER",2,""]